Skip to main content
VECTION TECHNOLOGIES LTD logo

VECTION TECHNOLOGIES LTD — Investor Relations & Filings

Ticker · VR1 ISIN · AU0000067522 LEI · 98450080CA1B62D2BC50 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 567 across all filing types
Latest filing 2021-04-26 Regulatory Filings
Country AU Australia
Listing ASX VR1

About VECTION TECHNOLOGIES LTD

https://vection-technologies.com

Vection Technologies Ltd specializes in the development of integrated Extended Reality (XR) solutions, encompassing Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR) technologies. The company provides a comprehensive suite of enterprise software designed to facilitate digital transformation across various sectors, including manufacturing, architecture, engineering, and defense. Key products include Mindesk, which enables real-time 3D design and CAD integration within immersive environments, and Enworks, an AR-driven platform for industrial training and maintenance. Additionally, the company offers FrameS for virtual collaboration and digital twin applications. Vection focuses on bridging the gap between physical and digital workflows, allowing organizations to visualize complex data, optimize design processes, and enhance operational efficiency through real-time immersive technology.

Recent filings

Filing Released Lang Actions
Appendix 2A 16 pages 333.3KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, references to previous announcements (Appendix 3B), and the purpose of the securities issuance (e.g., acquisition of an asset). This type of document is a regulatory announcement related to capital markets activity, specifically the listing or quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or legal proceeding. The document is a formal regulatory filing to the exchange about securities quotation, which fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. The document length is substantial (15,000 characters), and it contains detailed form data, not just a brief announcement or a certification. Therefore, the best classification is Regulatory Filings (RNS).
2021-04-26 English
Release of Shares from Voluntary Escrow 1 page 267.
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing the release of shares from voluntary escrow. It references compliance with ASX Listing Rule 3.10A and details about shares being released as part of an acquisition consideration. The document is short (1873 characters) and is an announcement rather than a detailed report or financial statement. It does not contain financial results, management discussion, or detailed regulatory filings. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital changes or director dealings, since it is about escrow release which is a regulatory compliance announcement.
2021-04-19 English
Vection to Acquire Leading Australian Archviz Studio 4 pages 320.4KB
M&A Activity Classification · 95% confidence The document is an ASX release announcing Vection Technologies Ltd's definitive agreement to acquire 100% of the issued capital of Blank Canvas Studios. It details the acquisition terms, strategic rationale, and key milestones related to the transaction. There are no financial statements or comprehensive financial performance data presented, nor is this a transcript, management report, or regulatory certification. The content focuses on the acquisition announcement and related transaction details, which fits the definition of M&A Activity filings. The document length is sufficient and contains substantive information about the merger/acquisition, not just a brief announcement or report publication notice.
2021-04-14 English
Proposed issue of Securities - VR1 7 pages 33.5KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Proposed issue of securities' and contains detailed information about a placement or other type of securities issue by Vection Technologies Ltd. It includes specifics such as the number and type of securities to be issued, the proposed issue date, consideration details, approvals required, and fees related to the issue. The content is focused on the announcement of a new securities issuance rather than a financial report or earnings release. There is no indication of financial statements, management discussion, or audit information. The document is a formal announcement regarding capital raising activities and changes in the capital structure. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is over 10,000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2021-04-14 English
Trading Halt 2 pages 347.1KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Vection Technologies Ltd regarding a trading halt requested under ASX Listing Rule 17.1. It states that the trading halt is pending an announcement related to a proposed material acquisition transaction. The document does not contain any financial data, detailed report content, or results. It is a short announcement notifying the market of the trading halt and the reason for it. Therefore, it is not a full report like an Annual Report, Interim Report, or Earnings Release, nor is it a merger filing or detailed management information. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about trading status and pending news.
2021-04-12 English
Additional Information on VR1 Healthcare & Pharma Vertical 2 pages 297.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 19 March 2021 providing additional information about the Healthcare & Pharma Division of Vection Technologies Ltd. It discusses a joint venture agreement, management involvement, shareholding structure, and business plans related to the new division. There are no financial statements, quarterly or annual results, nor any regulatory certifications or voting results. The content is an update on company operations and strategic business development rather than a formal financial report or regulatory filing. The document length is under 5,000 characters and it is an announcement of additional information rather than a full report. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.